Date Log
Submitted
June 15, 2022
Published
June 15, 2022
A rare pediatric case report of MOG positive parainfectious Longitudinal extensive Transverse myelitis
International Journal of Allied Medical Sciences and Clinical Research,
Vol. 10 No. 2 (2022): 2022 Volume - 10 Issue - 2
Abstract
MOG-AD is a distinct nosological entity with specific management and therapeutic requirements.1 Optic neuritis is the most frequent presenting phenotype. The disease course can be either monophasic or relapsing, with subsequent relapses most commonly involving the optic nerve. MOG-associated myelitis is a less frequent clinical phenotype observed in children at their initial event. In the present article, we present a rare pediatric case of clinically diagnosed transverse myelitis with a positive anti-MOG antibody. A 13 year-old patient presented with weakness on both legs and decreased sensation below T2 level with bowel and bladder retention 2 weeks preceding a varicella infection. MOGAD may be a severe relapsing and devastating disorder for a subgroup of patients. Moderate response to current standard chronic therapies. Additional safe and long-term efficacious treatment options are still much needed for children with relapsing MOGAD.
Keywords
Myelitis, Phenotype, Neuritis.
Shatanshi Shukla, Jean pratheesh, Vivek Sirolia, Siddarth Aggarwal, & Mamta Dhaneria. (2022). A rare pediatric case report of MOG positive parainfectious Longitudinal extensive Transverse myelitis. International Journal of Allied Medical Sciences and Clinical Research, 10(2), 233–235. https://doi.org/10.61096/ijamscr.v10.iss2.2022.233-235
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
References
-
1. De Mol C, Wong Y, van Pelt E, Wokke B, Siepman T, Neuteboom R et al. The Clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults. Mult Scler J. 2020;26(7):806-14. doi: 10.1177/1352458519845112.
2. Huppke P, Rostasy K, Karenfort M, Huppke B, Seidl R, Leiz S et al. Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients. Mult Scler. 2013;19(7):941-6. doi: 10.1177/1352458512466317, PMID 23128668.
3. Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A, et al. Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain. 2017;140(12):3128-38. doi: 10.1093/brain/awx276, PMID 29136091.
References
1. De Mol C, Wong Y, van Pelt E, Wokke B, Siepman T, Neuteboom R et al. The Clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults. Mult Scler J. 2020;26(7):806-14. doi: 10.1177/1352458519845112.
2. Huppke P, Rostasy K, Karenfort M, Huppke B, Seidl R, Leiz S et al. Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients. Mult Scler. 2013;19(7):941-6. doi: 10.1177/1352458512466317, PMID 23128668.
3. Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A, et al. Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain. 2017;140(12):3128-38. doi: 10.1093/brain/awx276, PMID 29136091.
2. Huppke P, Rostasy K, Karenfort M, Huppke B, Seidl R, Leiz S et al. Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients. Mult Scler. 2013;19(7):941-6. doi: 10.1177/1352458512466317, PMID 23128668.
3. Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A, et al. Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain. 2017;140(12):3128-38. doi: 10.1093/brain/awx276, PMID 29136091.